Literature DB >> 31226663

Thromboprophylaxis by rivaroxaban, aspirin, both, or placebo after hospitalization for medical illness.

Witold Z Tomkowski1, Bruce L Davidson2.   

Abstract

Entities:  

Keywords:  Aspirin; Medical inpatient; Prophylaxis; Rivaroxaban; Thrombosis

Year:  2019        PMID： 31226663     DOI： 10.1016/j.thromres.2019.06.002

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

1.  Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients.

Authors:  Alex C Spyropoulos; Walter Ageno; Gregory W Albers; C Gregory Elliott; Jonathan L Halperin; William R Hiatt; Gregory A Maynard; P Gabriel Steg; Jeffrey I Weitz; Wentao Lu; Theodore E Spiro; Elliot S Barnathan; Gary E Raskob
Journal:  J Am Coll Cardiol       Date:  2020-06-30       Impact factor: 24.094

2.  Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial.

Authors:  Alex C Spyropoulos; Mark Goldin; Walter Ageno; Gregory W Albers; C Gregory Elliott; William R Hiatt; Jonathan L Halperin; Gregory Maynard; P Gabriel Steg; Jeffrey I Weitz; Theodore E Spiro; Wentao Lu; Jessica Marsigliano; Gary E Raskob; Elliot S Barnathan
Journal:  TH Open       Date:  2022-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.